|
|
Article: New Products Are Expected to Be Introduced to the Cancer Vaccine Market over the Next Five Years.
- Article from:
- Business Wire
- Article date:
- January 4, 2006
CopyrightCOPYRIGHT 2006 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c30125) has announced the addition of the Espicom Business Intelligence Ltd report Cancer Vaccine Developments To 2011 to their offering.
After years of promise, the cancer vaccine market is on the verge of huge growth - if it can overcome the clinical, regulatory and pharmacoeconomic obstacles.
With a number of product launches expected over the next five years, this insightful market report takes a balanced view of the players and products that will shape this much awaited market sector.
With two cancer vaccines already launched, M-Vax in Switzerland and ...